2022-01-16 16:14:35 | 70
Dr Reddys introduces anti-COVID drug molnupiravir at Rs 35 per capsule

"Dr Reddy's Molflu™ will be priced at Rs 35 per capsule with 10 capsules contained per strip, and the total course of 40 capsules over 5 days costing Rs 1,400 making it among the most affordable treatment options available to patients," Dr Reddy's Laboratories said in a statement. 

It added that Molflu is expected to be available from early next week in pharmacies throughout the country with particular focus on states with high caseload of COVID-19.  


Earlier this year, Dr Reddy's had entered into a non-exclusive voluntary licensing agreement with Merck Sharpe Dohme (MSD) to manufacture and supply molnupiravir to India and over 100 low and middle-income countries (LMICs). A consortium of pharma companies, led by Dr Reddy's, collaborated to jointly sponsor, supervise and monitor the phase III clinical trials in India, and presented its findings to the Subject Expert Committee (SEC).